Literature DB >> 2652520

Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation.

T Osakabe1, H Uchida, Y Masaki, K Yokota, K Sato, Y Nakayama, M Ohkubo, K Kumano, T Endo, K Watanabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2652520

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.

Authors:  A Zeevi; M Woan; G Z Yao; R Venkataramanan; S Todo; T E Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  Inhibition of cyclin A gene expression in human B cells by an immunosuppressant mizoribine.

Authors:  S Hirohata; K Nakanishi; T Yanagida
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

3.  Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine.

Authors:  L A Turka; J Dayton; G Sinclair; C B Thompson; B S Mitchell
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

Review 4.  MTOR Signaling and Metabolism in Early T Cell Development.

Authors:  Guy Werlen; Ritika Jain; Estela Jacinto
Journal:  Genes (Basel)       Date:  2021-05-13       Impact factor: 4.096
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.